This award is close to $3 per share + PIP has other things going for it. Very nice risk/reward offered here at 1.75.
The total award when finalized, including interest and reimbursement of a portion of PharmAthene's attorneys' and expert witness fees, is estimated to be in excess of $190 million.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.